HRS-8364

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-8364, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects [Phase 1, Phase 2]